Compare FENC & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENC | ZH |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 279.7M |
| IPO Year | 2010 | 2021 |
| Metric | FENC | ZH |
|---|---|---|
| Price | $7.44 | $2.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 120.6K | ★ 294.2K |
| Earning Date | 03-24-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $47,538,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.78 | N/A |
| P/E Ratio | ★ N/A | $20.74 |
| Revenue Growth | ★ 123.69 | N/A |
| 52 Week Low | $4.68 | $2.87 |
| 52 Week High | $9.92 | $5.55 |
| Indicator | FENC | ZH |
|---|---|---|
| Relative Strength Index (RSI) | 41.25 | 25.78 |
| Support Level | $7.44 | N/A |
| Resistance Level | $8.19 | $4.53 |
| Average True Range (ATR) | 0.43 | 0.11 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 11.79 | 4.30 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.